This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2LT Bloedon , O Philippe & PO Szapary (2004) Flaxseed and cardiovascular risk. Nutr Rev 62, 18–27.
3E Ghisalberti (1997) Cardiovascular activity of naturally occurring lignans. Phytomedicine 4, 151–166.
5C Eliasson , A Kamal-Eldin , R Andersson & P Aman (2003) High-performance liquid chromatographic analysis of secoisolariciresinol diglucoside and hydroxycinnamic acid glucosides in flaxseed by alkaline extraction. J Chromatography A 1012, 151–159.
8K Prasad (2005) Hypocholesterolemic and antiatherosclerotic effect of flax lignan complex isolated from flaxseed. Atherosclerosis 179, 269–275.
9K Prasad (1999) Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation 99, 1355–1362.
10SJ Bhathena , AA Ali , C Haudenschild , P Latham , T Ranich , AI Mohamed , CT Hansen & MT Velasquez (2003) Dietary flaxseed meal is more protective than soy protein concentrate against hypertriglyceridemia and steatosis of the liver in an animal model of obesity. J Am Coll Nutr 22, 157–164.
11K Yamashita , S Ikeda & M Obayashi (2003) Comparative effects of flaxseed and sesame seed on vitamin E and cholesterol levels in rats. Lipids 38, 1249–1255.
12K Prasad (1997) Dietary flax seed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis 132, 69–76.
13EA Lucas , SA Lightfoot , LJ Hammond , (2004) Flaxseed reduces plasma cholesterol and atherosclerotic lesion formation in ovariectomized Golden Syrian hamsters. Atherosclerosis 173, 223–229.
14T Sano , E Oda , T Yamashita , H Shiramasa , Y Ijiri & J Yamamoto (2003) Antithrombic and anti-atherogenic effects of partially defatted flaxseed meal using a laser-induced thrombosis test in apolipoprotein E and low-density lipoprotein receptor deficient mice. Blood Coagul Fibrinolysis 14, 707–712.
19A Brzezinski & A Debi (1999) Phytoestrogens: the “natural” selective estrogen receptor modulators? Eur J Obstet Gynecol Reprod Biol 85, 47–51.
20W Insull Jr, MH Davidson , PM Kulkarni , S Siddhanti , AV Ciaccia & CA Keech (2005) Effects of raloxifene and low-dose simvastatin coadministration on plasma lipids in postmenopausal women with primary hypercholesterolemia. Metabolism 54, 939–946.
21C Lemieux , Y Gelinas , J Lalonde , F Labrie , K Cianflone & Y Deshaies (2005) Hypolipidemic action of the SERM acolbifene is associated with decreased liver MTP and increased SR-BI and LDL receptors. J Lipid Res 46, 1285–1294.
22W Demark-Wahnefried , CN Robertson , PJ Walther , TJ Polascik , DF Paulson & RT Vollmer (2004) Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen. Urology 63, 900–904.
23W Demark-Wahnefried , DT Price , TJ Polascik , CN Robertson , EE Anderson , DF Paulson , PJ Walther , M Gannon & RT Vollmer (2001) Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology 58, 47–52.
24C Stuglin & K Prasad (2005) Effect of flaxseed consumption on blood pressure, serum lipids, hemopoietic system and liver and kidney enzymes in healthy humans. J Cardiovasc Pharmacol Ther 10, 23–27.
25S Dodin , A Lemay , H Jacques , F Legare , JC Forest & B Masse (2005) Effect of flaxseed consumption on blood pressure, serum lipids, hemopoietic system, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 90, 1390–1397.
27ST Chen , SH Ferng , CS Yang , SJ Peng , HR Lee & JR Chen (2005) Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients. Am J Kidney Dis 46, 1099–1106.
28Y Henkin & I Shai (2003) Dietary treatment of hypercholesterolemia: can we predict long-term success? J Am Coll Nutr 22, 555–561.
29K Prasad , SV Mantha , AD Muir & ND Westcott (1998) Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low α-linolenic acid. Atherosclerosis 136, 367–375.
30EA Lucas , RD Wild , LJ Hammond , DA Khalil , S Juma , BP Daggy , BJ Stoecker & BH Arjmandi (2002) Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 87, 1527–1532.
31MT Clandinin , A Foxwell , YK Goh , K Layne & JA Jumpsen (1997) Omega-3 fatty acid intake results in a relationship between the fatty acid composition of LDL cholesterol ester and LDL cholesterol content in humans. Biochim Biophys Acta 1346, 247–252.
32PJ Nestel , SE Pomeroy , T Sasahara , T Yamashita , YL Liang , AM Dart , GL Jennings , M Abbey & JD Cameron (1997) Arterial compliance in obese subjects is improved with dietary plant n-3 fatty acid from flaxseed oil despite increased LDL oxidizability. Arterioscler Thromb Vasc Biol 17, 1163–1170.
34A Lemay , S Dodin , N Kadri , H Jacques & JC Forest (2002) Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Obstet Gynecol 100, 495–504.
36M Vanharanta , S Voutilainen , TA Lakka , M van der Lee , H Adlercreutz & JT Salonen (1999) Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study. Lancet 354, 2112–2115.
46MS Morton , G Wilcox , ML Wahlqvist & K Griffiths (1994) Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J Endocrinol 142, 251–259.